Cordlife Group Limited (CLIFF)
USD 0.3
(0.0%)
USD 0.3
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 228.45 Million SGD | 0.2% |
| 2022 | 227.99 Million USD | 31.63% |
| 2021 | 173.2 Million SGD | -1.84% |
| 2020 | 176.45 Million SGD | 5.8% |
| 2019 | 166.78 Million SGD | -21.58% |
| 2018 | 212.68 Million SGD | -2.54% |
| 2017 | 218.23 Million SGD | 9.81% |
| 2016 | 198.73 Million SGD | -26.55% |
| 2015 | 270.57 Million SGD | 9.42% |
| 2014 | 247.28 Million SGD | 29.67% |
| 2013 | 190.7 Million SGD | 58.33% |
| 2012 | 120.44 Million SGD | 33.29% |
| 2011 | 90.36 Million SGD | 63.14% |
| 2010 | 55.39 Million SGD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 Q1 | 234.03 Million SGD | 37.74% |
| 2023 Q2 | 172.97 Million USD | -26.09% |
| 2023 Q4 | 173.03 Million USD | -24.26% |
| 2023 FY | 228.45 Million SGD | 0.2% |
| 2023 Q3 | 228.45 Million SGD | 32.08% |
| 2022 Q1 | 228.1 Million SGD | -2.4% |
| 2022 FY | 227.99 Million USD | 31.63% |
| 2022 Q4 | 169.9 Million USD | -25.48% |
| 2022 Q3 | 227.99 Million SGD | 39.01% |
| 2022 Q2 | 164 Million SGD | -28.1% |
| 2021 Q1 | 227.91 Million SGD | -2.28% |
| 2021 Q3 | 233.71 Million SGD | 2.55% |
| 2021 Q4 | 233.71 Million SGD | 0.0% |
| 2021 FY | 173.2 Million SGD | -1.84% |
| 2021 Q2 | 227.91 Million SGD | 0.0% |
| 2020 Q2 | 233.19 Million SGD | 0.0% |
| 2020 Q3 | 233.21 Million SGD | 0.01% |
| 2020 Q4 | 233.21 Million SGD | 0.0% |
| 2020 FY | 176.45 Million SGD | 5.8% |
| 2020 Q1 | 233.19 Million SGD | 3.98% |
| 2019 Q4 | 224.27 Million SGD | 0.52% |
| 2019 Q1 | 214.36 Million SGD | 0.79% |
| 2019 FY | 166.78 Million SGD | -21.58% |
| 2019 Q2 | 214.62 Million SGD | 0.12% |
| 2019 Q3 | 223.1 Million SGD | 3.95% |
| 2018 Q2 | 218.23 Million SGD | 0.86% |
| 2018 FY | 212.68 Million SGD | -2.54% |
| 2018 Q4 | 212.68 Million SGD | 2.18% |
| 2018 Q3 | 208.14 Million SGD | -4.62% |
| 2018 Q1 | 216.37 Million SGD | 11.3% |
| 2017 Q4 | 194.4 Million SGD | 1.16% |
| 2017 FY | 218.23 Million SGD | 9.81% |
| 2017 Q3 | 192.17 Million SGD | -2.91% |
| 2017 Q2 | 197.94 Million SGD | 0.97% |
| 2017 Q1 | 196.03 Million SGD | 0.32% |
| 2016 Q4 | 195.4 Million SGD | -27.89% |
| 2016 FY | 198.73 Million SGD | -26.55% |
| 2016 Q3 | 270.96 Million SGD | 0.15% |
| 2016 Q2 | 270.57 Million SGD | -0.84% |
| 2016 Q1 | 272.85 Million SGD | -3.01% |
| 2015 FY | 270.57 Million SGD | 9.42% |
| 2015 Q4 | 281.32 Million SGD | -18.32% |
| 2015 Q3 | 344.42 Million SGD | 3.44% |
| 2015 Q2 | 332.96 Million SGD | 5.15% |
| 2015 Q1 | 316.65 Million SGD | 7.18% |
| 2014 Q1 | 176.16 Million SGD | -0.59% |
| 2014 Q4 | 295.43 Million SGD | 61.84% |
| 2014 Q3 | 182.55 Million SGD | -4.28% |
| 2014 Q2 | 190.7 Million SGD | 8.26% |
| 2014 FY | 247.28 Million SGD | 29.67% |
| 2013 Q3 | 126.1 Million SGD | 4.7% |
| 2013 Q4 | 177.2 Million SGD | 40.52% |
| 2013 FY | 190.7 Million SGD | 58.33% |
| 2013 Q1 | 99.99 Million SGD | 2.32% |
| 2013 Q2 | 120.44 Million SGD | 20.45% |
| 2012 Q1 | 90.5 Million SGD | 0.0% |
| 2012 FY | 120.44 Million SGD | 33.29% |
| 2012 Q2 | 90.36 Million SGD | -0.16% |
| 2012 Q4 | 97.72 Million SGD | 2.31% |
| 2012 Q3 | 95.51 Million SGD | 5.7% |
| 2011 Q2 | 55.39 Million SGD | 0.0% |
| 2011 FY | 90.36 Million SGD | 63.14% |
| 2010 FY | 55.39 Million SGD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| American Bio Medica Corporation | 1.26 Million USD | -17902.837% |
| Arrayit Corporation | 1 Million USD | -22736.717% |
| Atlantic International Corp. | 4.43 Million USD | -5049.626% |
| Biocept, Inc. | 30.87 Million USD | -639.986% |
| Bioqual, Inc. | 56.58 Million USD | -303.719% |
| CardioGenics Holdings Inc | 231.93 Thousand USD | -98401.285% |
| DermTech, Inc. | 121.93 Million USD | -87.367% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 4.18 Billion USD | 94.541% |
| HTG Molecular Diagnostics, Inc. | 17.77 Million USD | -1185.074% |
| iMD Companies, Inc. | 190.13 Thousand USD | -120053.363% |
| IDenta Corp. | 1.52 Million USD | -14838.844% |
| Interpace Biosciences, Inc. | 13.02 Million USD | -1654.52% |
| Integrative Health Technologies, Inc. | 8.25 Million USD | -2668.522% |
| InVitro International | 1.53 Million USD | -14792.761% |
| Lumos Diagnostics Holdings Limited | 26.83 Million USD | -751.241% |
| Many Bright Ideas Technologies Inc. | 2312.00 USD | -9881214.879% |
| Medical Imaging Corp. | 4.19 Million USD | -5350.294% |
| NovelStem International Corp. | 2.25 Million USD | -10033.127% |
| Optigenex Inc. | 1.88 Million USD | -11998.565% |
| PharmChem, Inc. | 2.76 Million USD | -8160.753% |
| Proteome Sciences plc | 14.58 Million USD | -1466.265% |
| Response Genetics, Inc | 48.88 Million USD | -367.343% |
| Rennova Health, Inc. | 20.57 Million USD | -1010.478% |
| RushNet, Inc. | 6.04 Million USD | -3677.629% |
| ScreenPro Security Inc. | 1.26 Million USD | -18011.894% |
| Stella Diagnostics Inc. | 472.42 Thousand USD | -48258.357% |
| StageZero Life Sciences Ltd. | 700.65 Thousand USD | -32506.201% |
| Todos Medical Ltd. | 15.26 Million USD | -1396.404% |